SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011560
Filing Date
2021-05-14
Accepted
2021-05-14 17:25:20
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1851443
2 ex31-1.htm EX-31.1 15555
3 ex32-1.htm EX-32.1 7456
  Complete submission text file 0001493152-21-011560.txt   6950636

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ppcb-20210331.xml EX-101.INS 1000235
5 XBRL SCHEMA FILE ppcb-20210331.xsd EX-101.SCH 67655
6 XBRL CALCULATION FILE ppcb-20210331_cal.xml EX-101.CAL 60871
7 XBRL DEFINITION FILE ppcb-20210331_def.xml EX-101.DEF 255327
8 XBRL LABEL FILE ppcb-20210331_lab.xml EX-101.LAB 468501
9 XBRL PRESENTATION FILE ppcb-20210331_pre.xml EX-101.PRE 349421
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 21926184
SIC: 2834 Pharmaceutical Preparations